DIPG-15. PNOC-003: CLINICAL IMPACT OF A PRECISION MEDICINE STRATEGY FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA

OBJECTIVE: We evaluated the impact on overall survival at 12 months (OS12) of a personalized therapy plan based on tumor/germline whole exome (WES) and tumor RNA sequencing (RNAseq) of diffuse intrinsic pontine glioma (DIPG). METHODS: We enrolled newly diagnosed DIPG patients ≤ 25 years of age. Tumo...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Neuro Oncol
المؤلفون الرئيسيون: Mueller, Sabine, Kline, Cassie, Kilburn, Lindsay, Liang, Winnie S, Jain, Payal, Gupta, Nalin, Panditharatna, Eshini, Nazemi, Kellie, Magge, Suresh N, Crawford, John, Banerjee, Anu, Packer, Roger, Roos, Alison, Zhang, Bo, Zhu, Yuankun, Aboian, Mariam, Tamrazi, Benita, Philips, Joanna, Solomon, David, Molinaro, Annette, Kuhn, John, Byron, Sara A, Nazarian, Javad, Resnick, Adam, Berens, Michael, Prados, Michael
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2019
الموضوعات:
Diffuse Intrinsic Pontine Glioma (DIPG)
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477269/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.036
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة